லோரி துளை News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from லோரி துளை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In லோரி துளை Today - Breaking & Trending Today
A new study is showing improved survival in men with advanced prostate cancer from an experimental drug that delivers radiation directly to tumor cells. ....
Doctors are reporting improved survival in men with advanced prostate cancer from an experimental drug that delivers radiation directly to tumor cells ....
Fox News Flash top headlines are here. Check out what s clicking on Foxnews.com. A pill has been shown to help keep certain early-stage, hard-to-treat breast cancers at bay after initial treatment in findings being reported early because they are so promising. Study results were released Thursday by the American Society of Clinical Oncology ahead of its annual meeting and published in the New England Journal of Medicine. The pill, called Lynparza, was found to help breast cancer patients with harmful mutations live longer without disease after their cancers had been treated with standard surgery and chemotherapy. It was studied in patients with mutations in genes known as BRCA1 and BRCA2 that can predispose people to breast cancer if they don t work properly, but who did not have a gene flaw that can be targeted by the drug Herceptin. ....
A pill has been shown to help keep certain early-stage, hard-to-treat breast cancers at bay after initial treatment in findings being reported early because they are so promising. Study results were released Thursday by the American Society of Clinical Oncology ahead of its annual meeting and published in the New England Journal of Medicine. The… ....
Doctors are reporting improved survival in men with advanced prostate cancer from an experimental drug that delivers radiation directly to tumor cells. Few such drugs are approved now, but the approach may become a new way to treat patients with other hard-to-reach or inoperable cancers. The study tested an emerging class of medicine called radiopharmaceuticals,… ....